2025 BRICS Summit: Launching a New Chapter in Global Health Equity
The upcoming 2025 BRICS summit in Rio de Janeiro is set to be a turning point for global health. With Vietnam joining under an expanded “11+10” partnership framework, the bloc now represents nearly half the world’s population and one-third of global economic output. This broader coalition holds unprecedented potential to reshape global governance, especially in health.
Systemic Gaps Demand Systemic Solutions
Global health cooperation is one of the summit’s six key priorities, highlighting the urgent need to address structural inequities exposed by COVID-19. The pandemic revealed glaring flaws, particularly in vaccine distribution. According to a UN document, as of mid-2022, Africa’s vaccination rate stalled at just 4.1%, while high-income nations secured doses through premium purchases. Amid ongoing geopolitical tensions—from the Russia-Ukraine conflict to crises in the Middle East—the world can’t afford delayed action.
From Vision to Action: BRICS Drives Innovation
At the Third BRICS Sherpas Meeting on June 30, members proposed transformative measures, including a “partnership for eliminating socially-determined diseases” to combat health disparities linked to poverty. They also identified regulatory gaps in AI-driven healthcare as a priority for joint standard-setting, underscoring BRICS’ commitment to forward-thinking collaboration.
China’s Role: Beyond Aid to Systemic Cooperation
As the largest economy in BRICS, China has shifted from unilateral vaccine aid to building systemic partnerships, exemplified by its collaboration with Brazil. Since 2018, Brazil’s Fiocruz Institute has worked closely with Chinese counterparts to promote an Infectious Diseases Research and Prevention Center, advancing joint research, technology transfers, and academic exchanges.
In 2019, the Fiocruz Institute integrated cutting-edge genome sequencing technology from the Chinese mainland’s biotech giant BGI Genomics, training Brazilian specialists to bolster local pandemic preparedness. A parallel initiative with Brazil’s Butantan Institute and China’s Sinovac, launched in June 2020, has been equally transformative. Their cooperation spans critical Phase III trials for COVID-19 vaccines, technology licensing, market authorization, and vaccine commercialization, representing a departure from the technology monopolization seen in some Western pharmaceutical firms.
Butantan Institute Director Dimas Covas stated that Sinovac’s technology transfer began in 2021. This move not only enabled domestic vaccine production but also offered a replicable model for empowering other developing nations. These initiatives embody President Xi Jinping’s call for a “global community of health for all.”
A New Paradigm for Global Health
BRICS is redefining global health governance by championing inclusivity, technology equity, and South-South cooperation. This coalition is accelerating a transformative shift, demonstrating that sustainable solutions come from collective action that bridges gaps and aligns priorities.
